<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Card Anaesth</journal-id><journal-id journal-id-type="iso-abbrev">Ann Card Anaesth</journal-id><journal-id journal-id-type="publisher-id">ACA</journal-id><journal-title-group><journal-title>Annals of Cardiac Anaesthesia</journal-title></journal-title-group><issn pub-type="ppub">0971-9784</issn><issn pub-type="epub">0974-5181</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27716694</article-id><article-id pub-id-type="pmc">5070323</article-id><article-id pub-id-type="publisher-id">ACA-19-638</article-id><article-id pub-id-type="doi">10.4103/0971-9784.191552</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Perioperative utility of goal-directed therapy in high-risk cardiac patients undergoing coronary artery bypass grafting: &#x0201c;A clinical outcome and biomarker-based study&#x0201d;</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kapoor</surname><given-names>Poonam Malhotra</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Magoon</surname><given-names>Rohan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Rawat</surname><given-names>Rajinder</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Mehta</surname><given-names>Yatin</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India</aff><aff id="aff2"><label>1</label>Department of Cardiac Anaesthesiology, Salalah Heart Center, Salalah, Oman</aff><aff id="aff3"><label>2</label>Department of Anaesthesiology and Critical Care, Medanta &#x02013; The Medicity, Gurgaon, Haryana, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Poonam Malhotra Kapoor, Department of Cardiac Anaesthesia, CTC, AIIMS, New Delhi, India. E-mail: <email xlink:href="drpoonamaiims@gmail.com">drpoonamaiims@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2016</year></pub-date><volume>19</volume><issue>4</issue><fpage>638</fpage><lpage>645</lpage><history><date date-type="received"><day>26</day><month>7</month><year>2016</year></date><date date-type="accepted"><day>03</day><month>8</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2016 Annals of Cardiac Anaesthesia</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><p>Goal-directed therapy (GDT) encompasses guidance of intravenous (IV) fluid and vasopressor/inotropic therapy by cardiac output or similar parameters to help in early recognition and management of high-risk cardiac surgical patients. With the aim of establishing the utility of perioperative GDT using robust clinical and biochemical outcomes, we conducted the present study. This multicenter randomized controlled study included 130 patients of either sex, with European system for cardiac operative risk evaluation &#x02265;3 undergoing coronary artery bypass grafting on cardiopulmonary bypass. The patients were randomly divided into the control and GDT group. All the participants received standardized care; arterial pressure monitored through radial artery, central venous pressure (CVP) through a triple lumen in the right internal jugular vein, electrocardiogram, oxygen saturation, temperature, urine output per hour, and frequent arterial blood gas (ABG) analysis. In addition, cardiac index (CI) monitoring using FloTrac&#x02122; and continuous central venous oxygen saturation (ScVO<sub>2</sub>) using PreSep&#x02122; were used in patients in the GDT group. Our aim was to maintain the CI at 2.5&#x02013;4.2 L/min/m<sup>2</sup>, stroke volume index 30&#x02013;65 ml/beat/m<sup>2</sup>, systemic vascular resistance index 1500&#x02013;2500 dynes/s/cm<sup>5</sup>/m<sup>2</sup>, oxygen delivery index 450&#x02013;600 ml/min/m<sup>2</sup>, continuous ScVO<sub>2</sub> &#x0003e;70%, and stroke volume variation &#x0003c;10%; in addition to the control group parameters such as CVP 6&#x02013;8 mmHg, mean arterial pressure 90&#x02013;105 mmHg, normal ABG values, oxygen saturation, hematocrit value &#x0003e;30%, and urine output &#x0003e;1 ml/kg/h. The aims were achieved by altering the administration of IV fluids and doses of inotropes or vasodilators. The data of sixty patients in each group were analyzed in view of ten exclusions. The average duration of ventilation (19.89 &#x000b1; 3.96 vs. 18.05 &#x000b1; 4.53 h, <italic>P</italic> = 0.025), hospital stay (7.94 &#x000b1; 1.64 vs. 7.17 &#x000b1; 1.93 days, <italic>P</italic> = 0.025), and Intensive Care Unit (ICU) stay (3.74 &#x000b1; 0.59 vs. 3.41 &#x000b1; 0.75 days, <italic>P</italic> = 0.012) was significantly less in the GDT group, compared to the control group. The extra volume added and the number of inotropic dose adjustments were significantly more in the GDT group. The two groups did not differ in duration of inotropic use, mortality, and other complications. The perioperative continuation of GDT affected the early decline in the lactate levels after 6 h in ICU, whereas the control group demonstrated a settling lactate only after 12 h. Similarly, the GDT group had significantly lower levels of brain natriuretic peptide, neutrophil gelatinase-associated lipocalin levels as compared to the control. The study clearly depicts the advantage of GDT for a favorable postoperative outcome in high-risk cardiac surgical patients.</p></abstract><kwd-group><kwd>Biomarker</kwd><kwd>Cardiac surgery</kwd><kwd>Goal-directed therapy</kwd><kwd>Outcome measures</kwd><kwd>Perioperative</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>After undergoing cardiac surgery, most patients have a short Intensive Care Unit (ICU) and hospital stay. However, up to 10% of patients have a complicated postoperative course because of organ dysfunction or multiple organ failure resulting in increased burden on the hospital resources and costs.[<xref rid="ref1" ref-type="bibr">1</xref>] Limited cardiovascular reserve and an inadequate hemodynamic response to postoperative surgical stress have been shown to be independent predictors of a prolonged ICU stay.[<xref rid="ref2" ref-type="bibr">2</xref><xref rid="ref3" ref-type="bibr">3</xref>]</p><p>Cardiac surgery, at present, is being conducted in an increasingly high-risk population as it is backed by continually improving surgical strategy and technology.[<xref rid="ref4" ref-type="bibr">4</xref>] Shoemaker <italic>et al</italic>. showed that high-risk cardiac surgical patients had increased morbidity and mortality and the survivors had consistently higher postoperative cardiac output and oxygen delivery than those who died.[<xref rid="ref5" ref-type="bibr">5</xref>] An understanding emerged that the high mortality rate might be reduced, if the flow-related cardiovascular values become additional goals for perioperative management. An indicator of low cardiac output, global tissue hypoxia is a key development proceeding to multiorgan failure and death.[<xref rid="ref6" ref-type="bibr">6</xref>] It is in the immediate postcardiopulmonary bypass (CPB) period when the recognition and treatment produce maximal benefit in outcome.[<xref rid="ref7" ref-type="bibr">7</xref>]</p><p>Goal-directed therapy (GDT) is a term used to describe the use of cardiac output or similar parameters to guide intravenous (IV) fluid and inotropic therapy.[<xref rid="ref8" ref-type="bibr">8</xref>] In the present study, GDT was used to optimize the various hemodynamic variables in the post-CPB period in high-risk patients with European system for cardiac operative risk evaluation (EuROSCORE)[<xref rid="ref9" ref-type="bibr">9</xref>] &#x02265;3 undergoing coronary artery bypass grafting (CABG) in the study group, whereas the control group comprised patients managed without using GDT. In the patients receiving GDT, the additional aims were to maintain the cardiac index (CI) between 2.5 and 4.2 L/min/m<sup>2</sup>, stroke volume index (SVI) 30&#x02013;65 ml/beat/m<sup>2</sup>, systemic vascular resistance index (SVRI) 1500&#x02013;2500 dynes/s/cm<sup>5</sup>/m<sup>2</sup>, oxygen delivery index (DO<sub>2</sub>I) 450&#x02013;600 ml/min/m<sup>2</sup>, continuous central venous oxygen saturation (ScVO<sub>2</sub>) &#x0003e;70%, and stroke volume variation (SVV) &#x0003c;10%. All data gathered in this study were derived using the FloTrac&#x02122; (a new minimally invasive cardiac output monitor) cardiac output sensor, and the PreSep&#x02122; catheter in conjunction with the Vigileo monitor (Edwards Life Sciences, Irvine, CA, USA).</p><p>Besides hemodynamic parameters, a plethora of biomarkers pertaining to myocardial, renal function, and the overall tissue perfusion have been described in recent years. The biomarkers such as brain natriuretic peptide (BNP) and neutrophil gelatinase-associated lipocalin (NGAL) correlate well with the clinical outcomes in various studies involving the use of GDT.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] This study also aimed at comparing the biomarkers between the patients undergoing CABG with or without GDT for establishing the utility of GDT in the perioperative care of high-risk cardiac surgical patients.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>MATERIALS AND METHODS</title><p>The study was conducted in two cardiac surgical centers after obtaining ethical clearance from the Institutional Review Board and informed consent. One hundred and thirty patients of either sex with a EuroSCORE &#x02265;3 undergoing CABG were included in this prospective randomized controlled study. The patients were divided randomly into two groups, namely, control and GDT groups, by the sealed envelope technique. Patients with cardiac dysrhythmias and contraindication to the central venous cannulation were excluded from the study. Patients requiring the initiation of intra-aortic balloon pump (IABP) therapy were excluded from the study because the FloTrac&#x02122; is not equipped to identify the waveforms of arterial pressure waveform while using IABP.</p><p>Induction and maintenance of general anesthesia was done in accordance with the institutional protocol. Electrocardiogram (ECG), oxygen saturation (SpO<sub>2</sub>), invasive blood pressure, central venous pressure (CVP) and arterial blood gas (ABG), urine output, and EtCO<sub>2</sub> monitoring were common to both the groups. In addition, the CI using FloTrac/volumeView set (Edwards Life Sciences Ltd.) and the ScVO<sub>2</sub> using PreSep catheter were monitored in the GDT group. A VolumeView&#x02122; cardiac output monitoring sensor was connected to the radial arterial cannula in the GDT group. PreSep&#x02122; catheter (continuous central venous oximetry) was inserted in the GDT group. The baseline readings (T<sub>1</sub>) of heart rate (HR), mean arterial pressure (MAP), CVP, SpO<sub>2</sub>, and ABG were recorded. The additional baseline readings (T<sub>1</sub>) of CI, SVRI, DO<sub>2</sub>I, SVI, SVV, and ScVO<sub>2</sub> were recorded in the patients in the GDT group. The blood samples were collected for T<sub>1</sub> values of BNP, NGAL, and lactate in all the patients.</p><p>The CPB was initiated after systemic heparinization and was maintained as per standard institutional protocols. The rewarming was accompanied by administering IV infusion of dobutamine at 5 &#x000b5;g/kg/min and 0.5 &#x000b5;g/kg/min nitroglycerin or any other vasoactive/vasodilator drug depending on patients&#x02019; condition. After separation from CPB, protamine sulfate was administered in a dose of 1.2 mg/mg of heparin to antagonize the effects of heparin. Thereafter, the patients received 0.1 U/kg of platelet transfusion. All patients received fluids to maintain the CVP between 6 and 8 mmHg[<xref rid="ref12" ref-type="bibr">12</xref>] and MAP was maintained between 90 and 105 mmHg using inotropic agents (dobutamine, dopamine, adrenaline, noradrenaline, and milrinone) and vasodilators. ABG and urinary output was monitored on an hourly basis, and the biochemical abnormalities corrected as necessary. Hematocrit (HCT) values were maintained at or above 30% with packed cell transfusions.</p><sec id="sec2-1"><title>The goal-directed therapy algorithm</title><p>In accordance with the GDT, if the CI was &#x0003c;2.5 L/min/m<sup>2</sup>, CVP &#x0003c;6 mmHg, or SVV &#x0003e;10%, fluids (100 ml aliquots of fluid) were given intravenously till the target CVP and SVV levels were achieved [<xref ref-type="fig" rid="F1">Figure 1</xref>]. Inotropic agents and vasodilators were adjusted to maintain the parameters within the target values. The choice of inotropes was determined by MAP, SV, and SVRI. If ScVO<sub>2</sub> was &#x0003c;70%, packed red cells were administered to maintain HCT &#x0003e;30% and if ScVO<sub>2</sub> continued to be &#x0003c;70%, GDT was initiated to achieve the CI at 2.5&#x02013;4.2 L/min/m<sup>2</sup>, SVI at 30&#x02013;65 ml/beat/m<sup>2</sup>, SVRI at 1600&#x02013;2600 dyne/s/cm<sup>5</sup>/m<sup>2</sup>, DO<sub>2</sub>I at 450&#x02013;600 ml/min/m<sup>2</sup>, ScVO<sub>2</sub> &#x0003e;70%, and SVV &#x0003c;10%; in addition to the goals in the standard care such as CVP 6&#x02013;8 mmHg, MAP at 90&#x02013;105 mmHg, ABG analysis values (pH 7.35&#x02013;45, PaO<sub>2</sub> &#x0003e;100 mmHg, and PaCO<sub>2</sub> 35&#x02013;45 mmHg), SpO<sub>2</sub> &#x0003e;95%, HCT &#x0003e;30%, and urine output &#x0003e;1 ml/kg/h. The monitoring was gradually withdrawn after 24 h.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The step-wise algorithm followed in the study to allocate, study, and manage the patients receiving goal-directed and conventional therapy</p></caption><graphic xlink:href="ACA-19-638-g001"/></fig><p>The parameters recorded at the closure of sternum were designated as T<sub>2</sub> and blood lactate (T<sub>2</sub>) was estimated. All patients were mechanically ventilated in the ICU and monitored with FlowTrac for 24 h. HR, MAP, SpO<sub>2</sub>, CVP, and peripheral temperature were monitored continuously and recorded at 0 (T<sub>3</sub>), 6 (T<sub>4</sub>), 12 (T<sub>5</sub>), and 24 (T<sub>6</sub>) h after transfer to the ICU. Blood samples were collected postoperatively at 6 and 24 h for T<sub>4</sub> and T<sub>6</sub> values of BNP and NGAL and 0, 6, 12, and 24 h for T<sub>3</sub>, T<sub>4</sub>, T<sub>5</sub>, and T<sub>6</sub> values of lactate.</p><p>Early postoperative care in the ICU was jointly determined by the cardiac surgical and ICU staff, as per standard practice. Patients were weaned off when they were fully awake and adequately rewarmed (core temperature &#x02265;36&#x000b0;) with normal skeletal muscle power, hemodynamically stable with normal chest radiograph and ABG, chest-tube drainage &#x0003c;100 ml/h, and urine output &#x0003e;1 ml/kg/h. All extubated patients were transferred from the ICU on the 2<sup>nd</sup> day unless inotropes or vasodilator drugs were necessary. A 12-lead ECG was performed on the day 3. The criteria for discharge from hospital comprised a stable cardiac rhythm, oral temperature &#x0003c;99&#x000b0;F, HCT &#x02265;25%, oral intake of a minimum of 1000 calories/day, and successful completion of exercise testing that included independent ambulation, no significant wound-related complications, and an adequate home support system. Patients were contacted by phone at 30 days and their medical records reviewed to ascertain if they experienced any adverse outcomes.</p></sec><sec id="sec2-2"><title>Statistical analysis</title><p>Discrete categorical data were presented as number or percentage. The normality of quantitative data was checked by measures of Kolmogorov&#x02013;Smirnov tests of normality. Continuous data were written either in the form of its mean and standard deviation or in the form of its median and interquartile range, as per the requirement. For normally distributed data, <italic>t</italic>-test was applied for statistical analysis of two groups. For skewed data, nonparametric Mann&#x02013;Whitney U-test was used for statistical analysis of two groups. For time-related variable, Wilcoxon signed-rank test was applied. For categorical data, comparisons were made by Pearson's Chi-square test or Fisher's exact test as appropriate. All the statistical tests were two-sided and were performed at a significance level of &#x003b1; = 0.05. Analysis was conducted using IBM SPSS Statistics (version 22.0, IBM corporation, USA).</p></sec></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>To begin with, there were a total of 130 patients. Five patients from both the groups were excluded from the study since three patients in the control and one in the GDT group required IABP and postoperative atrial or ventricular fibrillation resulted in two and four patients in the control and the study group, respectively. The results of the remaining sixty patients in each group were analyzed. Demographic data and EuroSCORE, duration of CPB, duration of aortic cross-clamping (AOXCL), and an average number of grafts/patient were comparable [<xref ref-type="table" rid="T1">Table 1</xref>]. HR, MAP, CVP, SpO<sub>2</sub>, and ABG at various time intervals were comparable between the groups [<xref ref-type="table" rid="T2">Table 2</xref>]. The patients in the GDT group produced more urine during the study period, which was not statistically significant from the result of the control. ScVO<sub>2</sub>, CI, SVV, SVRI, SVI, and DO<sub>2</sub>I were maintained within the physiological values in the GDT group.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic characteristics of the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">Control group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1">GDT group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">61.30&#x000b1;5.60*</td><td align="center" rowspan="1" colspan="1">61.17&#x000b1;5.09*</td><td align="center" rowspan="1" colspan="1">0.892</td></tr><tr><td align="left" rowspan="1" colspan="1">Male:female</td><td align="center" rowspan="1" colspan="1">42:18</td><td align="center" rowspan="1" colspan="1">40:20</td><td align="center" rowspan="1" colspan="1">0.695</td></tr><tr><td align="left" rowspan="1" colspan="1">Height (cm)</td><td align="center" rowspan="1" colspan="1">160.70&#x000b1;5.18*</td><td align="center" rowspan="1" colspan="1">159.98&#x000b1;3.30*</td><td align="center" rowspan="1" colspan="1">0.448</td></tr><tr><td align="left" rowspan="1" colspan="1">Weight (kg)</td><td align="center" rowspan="1" colspan="1">72.90&#x000b1;8.79*</td><td align="center" rowspan="1" colspan="1">72.97&#x000b1;9.39*</td><td align="center" rowspan="1" colspan="1">0.968</td></tr><tr><td align="left" rowspan="1" colspan="1">EuroSCORE</td><td align="center" rowspan="1" colspan="1">4.15&#x000b1;0.84*</td><td align="center" rowspan="1" colspan="1">4.13&#x000b1;0.81*</td><td align="center" rowspan="1" colspan="1">0.955</td></tr><tr><td align="left" rowspan="1" colspan="1">CPB (min)</td><td align="center" rowspan="1" colspan="1">99.22&#x000b1;6.66*</td><td align="center" rowspan="1" colspan="1">99.08&#x000b1;7.63*</td><td align="center" rowspan="1" colspan="1">0.919</td></tr><tr><td align="left" rowspan="1" colspan="1">AOXCL (min)</td><td align="center" rowspan="1" colspan="1">57.57&#x000b1;4.00*</td><td align="center" rowspan="1" colspan="1">57.50&#x000b1;5.20*</td><td align="center" rowspan="1" colspan="1">0.937</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of grafts</td><td align="center" rowspan="1" colspan="1">3.43&#x000b1;0.64*</td><td align="center" rowspan="1" colspan="1">3.53&#x000b1;0.79*</td><td align="center" rowspan="1" colspan="1">0.695</td></tr></tbody></table><table-wrap-foot><fn><p>*Standard deviation, <italic>P</italic>&#x0003c;0.05 is considered significant. GDT: Goal-directed therapy, CPB: Cardiopulmonary bypass, AOXCL: Aortic cross clamping, EuroSCORE: European system for cardiac operative risk evaluation</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Heart rate, mean arterial pressure, and central venous pressure in the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">Time</th><th align="center" rowspan="1" colspan="1">Control group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1">GDT group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="6" valign="top" colspan="1">Heart rate</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">69.42&#x000b1;5.02*</td><td align="center" rowspan="1" colspan="1">68.17&#x000b1;6.85*</td><td align="center" rowspan="1" colspan="1">0.257</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>2</sub></td><td align="center" rowspan="1" colspan="1">92.18&#x000b1;7.24*</td><td align="center" rowspan="1" colspan="1">93.75&#x000b1;6.51</td><td align="center" rowspan="1" colspan="1">0.215</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>3</sub></td><td align="center" rowspan="1" colspan="1">99.75&#x000b1;8.29*</td><td align="center" rowspan="1" colspan="1">100.45&#x000b1;7.69*</td><td align="center" rowspan="1" colspan="1">0.633</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">99.95&#x000b1;8.30*</td><td align="center" rowspan="1" colspan="1">102.37&#x000b1;6.13*</td><td align="center" rowspan="1" colspan="1">0.072</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>5</sub></td><td align="center" rowspan="1" colspan="1">101.95&#x000b1;8.60*</td><td align="center" rowspan="1" colspan="1">103.33&#x000b1;6.10*</td><td align="center" rowspan="1" colspan="1">0.312</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">100.00&#x000b1;6.81*</td><td align="center" rowspan="1" colspan="1">100.92&#x000b1;7.11*</td><td align="center" rowspan="1" colspan="1">0.473</td></tr><tr><td align="left" rowspan="6" valign="top" colspan="1">MAP</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">89.33&#x000b1;6.98*</td><td align="center" rowspan="1" colspan="1">91.57&#x000b1;7.17*</td><td align="center" rowspan="1" colspan="1">0.087</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>2</sub></td><td align="center" rowspan="1" colspan="1">94.20&#x000b1;6.54*</td><td align="center" rowspan="1" colspan="1">94.78&#x000b1;6.85*</td><td align="center" rowspan="1" colspan="1">0.634</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>3</sub></td><td align="center" rowspan="1" colspan="1">96.07&#x000b1;6.06*</td><td align="center" rowspan="1" colspan="1">97.82&#x000b1;4.16*</td><td align="center" rowspan="1" colspan="1">0.068</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">94.73&#x000b1;6.37*</td><td align="center" rowspan="1" colspan="1">96.78&#x000b1;5.65*</td><td align="center" rowspan="1" colspan="1">0.065</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>5</sub></td><td align="center" rowspan="1" colspan="1">94.98&#x000b1;5.39*</td><td align="center" rowspan="1" colspan="1">97.02&#x000b1;5.91*</td><td align="center" rowspan="1" colspan="1">0.052</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">98.30&#x000b1;6.38*</td><td align="center" rowspan="1" colspan="1">100.45&#x000b1;5.59*</td><td align="center" rowspan="1" colspan="1">0.052</td></tr><tr><td align="left" rowspan="6" valign="top" colspan="1">CVP</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">6.50&#x000b1;0.93*</td><td align="center" rowspan="1" colspan="1">6.08&#x000b1;1.09*</td><td align="center" rowspan="1" colspan="1">0.117</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>2</sub></td><td align="center" rowspan="1" colspan="1">6.42&#x000b1;0.56*</td><td align="center" rowspan="1" colspan="1">6.45&#x000b1;0.77*</td><td align="center" rowspan="1" colspan="1">0.753</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>3</sub></td><td align="center" rowspan="1" colspan="1">6.22&#x000b1;0.49*</td><td align="center" rowspan="1" colspan="1">6.35&#x000b1;0.58*</td><td align="center" rowspan="1" colspan="1">0.175</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">6.17&#x000b1;0.46*</td><td align="center" rowspan="1" colspan="1">6.3&#x000b1;0.80*</td><td align="center" rowspan="1" colspan="1">0.182</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>5</sub></td><td align="center" rowspan="1" colspan="1">6.37&#x000b1;0.48*</td><td align="center" rowspan="1" colspan="1">6.4&#x000b1;0.58*</td><td align="center" rowspan="1" colspan="1">0.736</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">6.28&#x000b1;0.52*</td><td align="center" rowspan="1" colspan="1">6.53&#x000b1;0.87*</td><td align="center" rowspan="1" colspan="1">0.059</td></tr></tbody></table><table-wrap-foot><fn><p>*Standard deviation, <italic>P</italic>&#x0003c;0.05 is considered significant. T<sub>1</sub> (baseline), T<sub>2</sub> (sternal closure), T<sub>3</sub> (0), T<sub>4</sub> (6), T<sub>5</sub> (12), T<sub>6</sub> (24) h in ICU. ICU: Intensive Care Unit, MAP: Mean arterial pressure, CVP: Central venous pressure, GDT: Goal-directed therapy</p></fn></table-wrap-foot></table-wrap><p>There was statistically significant difference in the extra volume used (343.33 &#x000b1; 62.02 and 376.33 &#x000b1; 55.23, <italic>P</italic> = 0.003) and the number of times the inotropic agent was changed (2.77 &#x000b1; 0.91 and 3.12 &#x000b1; 0.80, <italic>P</italic> = 0.029) in the control and GDT groups, respectively [<xref ref-type="table" rid="T3">Table 3</xref>]. The average duration of ventilation (19.89 &#x000b1; 3.96 vs. 18.05 &#x000b1; 4.53 h, <italic>P</italic> = 0.025), hospital stay (7.94 &#x000b1; 1.64 vs. 7.17 &#x000b1; 1.93d, <italic>P</italic> = 0.025), and ICU stay (3.74 &#x000b1; 0.59 vs. 3.41 &#x000b1; 0.75 d, <italic>P</italic> = 0.012) was significantly less in the GDT group, compared to those in the control group [<xref ref-type="table" rid="T3">Table 3</xref>]. The duration of inotropic support was less in the GDT group though not significant as compared to the control. One patient in GDT group and three patients in the control group had renal dysfunction, which improved by administering diuretics. Total four patients (one in GDT and three in control) required IABP support. There were two mortalities in the study group and six mortalities in the control group during the study period. The causes ranged from malignant arrhythmias to refractory hemodynamic instability.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Comparison of the outcomes between the control and the goal-directed therapy group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameter</th><th align="center" rowspan="1" colspan="1">Control group</th><th align="center" rowspan="1" colspan="1">GDT group</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Average extra volume added</td><td align="center" rowspan="1" colspan="1">343.33&#x000b1;62.02*</td><td align="center" rowspan="1" colspan="1">376.33&#x000b1;55.23*</td><td align="center" rowspan="1" colspan="1">0.003</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of times inotropes adjusted</td><td align="center" rowspan="1" colspan="1">2.77&#x000b1;0.91*</td><td align="center" rowspan="1" colspan="1">3.12&#x000b1;0.80*</td><td align="center" rowspan="1" colspan="1">0.029</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of ventilation (h)</td><td align="center" rowspan="1" colspan="1">19.89&#x000b1;3.96*</td><td align="center" rowspan="1" colspan="1">18.05&#x000b1;4.53*</td><td align="center" rowspan="1" colspan="1">0.025</td></tr><tr><td align="left" rowspan="1" colspan="1">Duration of inotrope usage (days)</td><td align="center" rowspan="1" colspan="1">3.09&#x000b1;0.59*</td><td align="center" rowspan="1" colspan="1">2.81&#x000b1;0.94*</td><td align="center" rowspan="1" colspan="1">0.063</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of ICU stay (days)</td><td align="center" rowspan="1" colspan="1">3.74&#x000b1;0.59*</td><td align="center" rowspan="1" colspan="1">3.41&#x000b1;0.75*</td><td align="center" rowspan="1" colspan="1">0.012</td></tr><tr><td align="left" rowspan="1" colspan="1">Length of hospital stay (days)</td><td align="center" rowspan="1" colspan="1">7.94&#x000b1;1.64*</td><td align="center" rowspan="1" colspan="1">7.17&#x000b1;1.93*</td><td align="center" rowspan="1" colspan="1">0.025</td></tr><tr><td align="left" rowspan="1" colspan="1">Mortality</td><td align="center" rowspan="1" colspan="1">6/60</td><td align="center" rowspan="1" colspan="1">2/60</td><td align="center" rowspan="1" colspan="1">0.272</td></tr></tbody></table><table-wrap-foot><fn><p>*Standard deviation, <italic>P</italic>&#x0003c;0.05 is considered significant. Apart from the first two parameters, the <italic>n</italic> for the outcome measures for the control group was 54 and 58 for the GDT group in view of the mortality. GDT: Goal-directed therapy, ICU: Intensive Care Unit</p></fn></table-wrap-foot></table-wrap><p>With regard to the biomarkers, the continuation of GDT in the ICU helped reduction in the lactate levels at T<sub>4</sub> onward, whereas the control group recorded maximum lactate levels at T<sub>5</sub> [<xref ref-type="table" rid="T4">Table 4</xref>]. At the same time, BNP and NGAL were significantly higher in the control group at T<sub>6</sub> compared to the GDT group [<xref ref-type="table" rid="T4">Table 4</xref>].</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Comparison of biomarkers between the two groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Biomarker</th><th align="center" rowspan="1" colspan="1">Time</th><th align="center" rowspan="1" colspan="1">Control group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1">GDT group (<italic>n</italic>=60)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="3" valign="top" colspan="1">BNP (pg/mL)</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">152.27&#x000b1;11.60*</td><td align="center" rowspan="1" colspan="1">153.72&#x000b1;9.41*</td><td align="center" rowspan="1" colspan="1">0.454</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">187.85&#x000b1;13.34*</td><td align="center" rowspan="1" colspan="1">184.20&#x000b1;10.24*</td><td align="center" rowspan="1" colspan="1">0.095</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">207.70&#x000b1;28.44*</td><td align="center" rowspan="1" colspan="1">198.98&#x000b1;9.33*</td><td align="center" rowspan="1" colspan="1">0.026</td></tr><tr><td align="left" rowspan="3" valign="top" colspan="1">NGAL (ng/mL)</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">77.45&#x000b1;12.86*</td><td align="center" rowspan="1" colspan="1">81.25&#x000b1;11.29*</td><td align="center" rowspan="1" colspan="1">0.088</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">116.95&#x000b1;16.76*</td><td align="center" rowspan="1" colspan="1">112.62&#x000b1;9.79*</td><td align="center" rowspan="1" colspan="1">0.086</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">127.45&#x000b1;13.52*</td><td align="center" rowspan="1" colspan="1">122.18&#x000b1;8.85*</td><td align="center" rowspan="1" colspan="1">0.013</td></tr><tr><td align="left" rowspan="6" valign="top" colspan="1">Lactate (mmol/L)</td><td align="center" rowspan="1" colspan="1">T<sub>1</sub></td><td align="center" rowspan="1" colspan="1">1.00&#x000b1;0.30*</td><td align="center" rowspan="1" colspan="1">1.01&#x000b1;0.29*</td><td align="center" rowspan="1" colspan="1">0.752</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>2</sub></td><td align="center" rowspan="1" colspan="1">2.00&#x000b1;0.60*</td><td align="center" rowspan="1" colspan="1">2.03&#x000b1;0.59*</td><td align="center" rowspan="1" colspan="1">0.752</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>3</sub></td><td align="center" rowspan="1" colspan="1">2.52&#x000b1;0.40*</td><td align="center" rowspan="1" colspan="1">2.38&#x000b1;0.47*</td><td align="center" rowspan="1" colspan="1">0.015</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>4</sub></td><td align="center" rowspan="1" colspan="1">4.72&#x000b1;0.43*</td><td align="center" rowspan="1" colspan="1">4.51&#x000b1;0.53*</td><td align="center" rowspan="1" colspan="1">0.024</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>5</sub></td><td align="center" rowspan="1" colspan="1">5.22&#x000b1;0.64*</td><td align="center" rowspan="1" colspan="1">4.14&#x000b1;0.55*</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" rowspan="1" colspan="1">T<sub>6</sub></td><td align="center" rowspan="1" colspan="1">3.77&#x000b1;0.31*</td><td align="center" rowspan="1" colspan="1">3.23&#x000b1;0.41*</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn><p>*Standard deviation, <italic>P</italic>&#x0003c;0.05 is considered significant). T<sub>1</sub> (baseline), T<sub>2</sub> (sternal closure), T<sub>3</sub> (0), T<sub>4</sub> (6), T<sub>5</sub> (12), T<sub>6</sub> (24) h in ICU. ICU: Intensive Care Unit, GDT: Goal-directed therapy, BNP: Brain natriuretic peptide, NGAL: Neutrophil gelatinase-associated lipocalin</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>Organ dysfunction and multiple organ failure remain the main causes of prolonged hospital stay after cardiac surgery.[<xref rid="ref1" ref-type="bibr">1</xref>] Cardiac surgery patients are at risk of inadequate oxygen delivery in view of extracorporeal circulation and limited cardiovascular reserve.[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref13" ref-type="bibr">13</xref>]</p><p>The aim of GDT is to maintain the CI, CVP, MAP, SVRI, DO<sub>2</sub>I, SVI, SVV, ScVO<sub>2</sub>, ABG, and urine output within the physiological limits by active intervention. P&#x000f6;l&#x000f6;nen <italic>et al</italic>. studied 403 cardiac surgery patients and concluded that maintaining mixed venous oxygen saturation (SvO2) &#x0003e;70%, decreases the length of stay (LOS)-ICU and LOS-hospital.[<xref rid="ref13" ref-type="bibr">13</xref>] Patients in the high-risk group who tend to have increased morbidity and mortality may benefit from intensive monitoring and early interventions. Therefore, in this study, we wished to study the utility of GDT in patients who with EuroSCORE &#x02265;3 points (medium and high-risk).</p><p>Mixed venous oxygen saturation is ideally measured by estimating the oxygen content of the blood drawn from the pulmonary artery through pulmonary artery catheter (PAC). Goldman <italic>et al</italic>. studied the importance of ScVO<sub>2</sub> in 31 patients with myocardial infarction.[<xref rid="ref14" ref-type="bibr">14</xref>] PreSep&#x02122; central venous oximetry catheter can be used to continuously monitor the ScVO<sub>2</sub> (though not similar to SvO<sub>2</sub>, correlates well with SvO<sub>2</sub>). The mixed venous oxygen saturation estimated from the superior vena cava was found to be 5%&#x02013;13% lower than that estimated from the PAC.[<xref rid="ref15" ref-type="bibr">15</xref>]</p><p>In cardiac surgery, GDT was commenced using a noninvasive method such as esophageal Doppler instead of the PAC to measure the cardiac output.[<xref rid="ref16" ref-type="bibr">16</xref><xref rid="ref17" ref-type="bibr">17</xref><xref rid="ref18" ref-type="bibr">18</xref>] Unlike the FloTrac&#x02122;, Doppler probe is not readily tolerated by conscious patients, restricting its use to patients who are ventilated, and the PAC is invasive with its own set of complications.[<xref rid="ref8" ref-type="bibr">8</xref>] Studies by Manecke <italic>et al</italic>., McGee <italic>et al</italic>., and Chakravarthy <italic>et al</italic>., have validated the Vigileo system.[<xref rid="ref19" ref-type="bibr">19</xref><xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref>] However, Opdam <italic>et al</italic>. showed a limited correlation for CI between FloTrac&#x02122; and PAC.[<xref rid="ref22" ref-type="bibr">22</xref>] A study by Smetkin <italic>et al</italic>. showed that a goal-directed algorithm based on continuous measurement of ScVO<sub>2</sub> could improve the course of the postoperative period after CABG on the beating heart.[<xref rid="ref23" ref-type="bibr">23</xref>] In a 15-year follow-up, Rhodes <italic>et al</italic>. evaluated GDT in high-risk surgical patients, demonstrating improved long-term outcomes.[<xref rid="ref24" ref-type="bibr">24</xref>]</p><p>The authors had previously conducted a clinical outcome comparison study between the GDT and the control groups in a small number of patients with inconclusive results.[<xref rid="ref25" ref-type="bibr">25</xref>] Keeping in view the advent and validation of biomarkers for predicting organ dysfunction after cardiac surgery,[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] the authors planned a comparison between the GDT and conventional hemodynamic management with clinical and biochemical outcomes in a larger number of patients.</p><p>The average duration of ventilation, hospital stay, ICU stay was significantly less in the GDT group, compared to those in the control group [<xref ref-type="table" rid="T3">Table 3</xref>]. The duration of inotropic support was less in the GDT group though not significant as compared to the control. There was statistically significant difference in the extra volume used and the number of times the inotropic agent was changed in the control and GDT groups, both being higher in the GDT group to meet the desired hemodynamic goals.</p><p>As depicted in <xref ref-type="fig" rid="F2">Figure 2</xref>, the continuation of GDT in the perioperative period in the ICU helped in stabilization of the lactate levels at T<sub>4</sub> onward, whereas the control group recorded maximum lactate levels at T<sub>5.</sub> It was noteworthy that NGAL levels (as well as BNP) were significantly higher in the control group after 24 h as compared to the GDT group though the urine output difference between the groups was still insignificant [<xref ref-type="fig" rid="F3">Figure 3</xref>]. This highlights the importance of biomarkers in early detection of organ dysfunction after cardiac surgery. Close hemodynamic, clinical, and biomarker-based monitoring continued from the perioperative to the intensive care setting provides early mobilization in a safe manner postcardiac surgery.[<xref rid="ref26" ref-type="bibr">26</xref><xref rid="ref27" ref-type="bibr">27</xref><xref rid="ref28" ref-type="bibr">28</xref>]</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>The lactate at T<sub>1</sub> (baseline), T<sub>2</sub> (sternal closure), T<sub>3</sub> (0), T<sub>4</sub> (6), T<sub>5</sub> (12), and T<sub>6</sub> (24) h in Intensive Care Unit. The arrow shows the peak in the groups</p></caption><graphic xlink:href="ACA-19-638-g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>The brain natriuretic peptide, neutrophil gelatinase-associated lipocalin, average hourly urine output at T<sub>1</sub>, T<sub>4</sub>, T<sub>6</sub>, where the rise in brain natriuretic peptide/neutrophil gelatinase-associated lipocalin is clear at T<sub>6</sub></p></caption><graphic xlink:href="ACA-19-638-g003"/></fig><sec id="sec2-3"><title>Limitations</title><p>This study had a few limitations: In spite of involving a considerable number of patients in a randomized fashion, the study could not be blinded. Second, the present study being a multicenter study, the patients enrolled in the study were operated upon by center-specific surgical teams. Preload markers of global end-diastolic volume index and extravascular lung water could not be completed in all sixty patients; hence their values were not included in the study. These markers which give more information on volume status should be part of a futuristic trial, as it substantiates adequately the efficacy of GDT.</p></sec></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>Perioperative GDT can shorten the duration of ventilator dependency, ICU and hospital stay in high-risk cardiac surgical patients. The significantly lower levels of biomarkers in GDT group further support the importance of optimizing the hemodynamic parameters for the maintenance of tissue perfusion. This attests to the cost-effectiveness of GDT in the management of a subset of patients at higher risk of morbidity and mortality after cardiac surgery.</p><sec id="sec2-4"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-5"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgins</surname><given-names>TL</given-names></name><name><surname>Yared</surname><given-names>JP</given-names></name><name><surname>Ryan</surname><given-names>T</given-names></name></person-group><article-title>Immediate postoperative care of cardiac surgical patients</article-title><source>J Cardiothorac Vasc Anesth</source><year>1996</year><volume>10</volume><fpage>643</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">8841875</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>Rady</surname><given-names>MY</given-names></name><name><surname>Bashour</surname><given-names>CA</given-names></name><name><surname>Leventhal</surname><given-names>M</given-names></name><name><surname>Lytle</surname><given-names>B</given-names></name><name><surname>Starr</surname><given-names>NJ</given-names></name></person-group><article-title>Predictors of outcome in cardiac surgical patients with prolonged intensive care stay</article-title><source>Chest</source><year>1997</year><volume>112</volume><fpage>1035</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">9377914</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routsi</surname><given-names>C</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Bakker</surname><given-names>J</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Lejeune</surname><given-names>P</given-names></name><name><surname>d&#x02019;Hollander</surname><given-names>A</given-names></name><etal/></person-group><article-title>Relation between oxygen consumption and oxygen delivery in patients after cardiac surgery</article-title><source>Anesth Analg</source><year>1993</year><volume>77</volume><fpage>1104</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">8250298</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>CD</given-names></name><name><surname>Weintraub</surname><given-names>WS</given-names></name><name><surname>Craver</surname><given-names>JM</given-names></name><name><surname>Jones</surname><given-names>EL</given-names></name><name><surname>Gott</surname><given-names>JP</given-names></name><name><surname>Guyton</surname><given-names>RA</given-names></name></person-group><article-title>Effect of cardiac surgery patient characteristics on patient outcomes from 1981 through 1995</article-title><source>Circulation</source><year>1997</year><volume>96</volume><fpage>1575</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">9315549</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoemaker</surname><given-names>WC</given-names></name><name><surname>Appel</surname><given-names>PL</given-names></name><name><surname>Waxman</surname><given-names>K</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>P</given-names></name></person-group><article-title>Clinical trial of survivors&#x02019; cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients</article-title><source>Crit Care Med</source><year>1982</year><volume>10</volume><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">7042206</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bland</surname><given-names>R</given-names></name><name><surname>Shoemaker</surname><given-names>WC</given-names></name><name><surname>Shabot</surname><given-names>MM</given-names></name></person-group><article-title>Physiologic monitoring goals for the critically ill patient</article-title><source>Surg Gynecol Obstet</source><year>1978</year><volume>147</volume><fpage>833</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">31006</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>AL</given-names></name><name><surname>Cerra</surname><given-names>FB</given-names></name></person-group><article-title>Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction</article-title><source>JAMA</source><year>1994</year><volume>271</volume><fpage>226</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">8080494</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearse</surname><given-names>R</given-names></name><name><surname>Dawson</surname><given-names>D</given-names></name><name><surname>Fawcett</surname><given-names>J</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name><name><surname>Grounds</surname><given-names>RM</given-names></name><name><surname>Bennett</surname><given-names>ED</given-names></name></person-group><article-title>Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]</article-title><source>Crit Care</source><year>2005</year><volume>9</volume><fpage>R687</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">16356219</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nashef</surname><given-names>SA</given-names></name><name><surname>Roques</surname><given-names>F</given-names></name><name><surname>Michel</surname><given-names>P</given-names></name><name><surname>Gauducheau</surname><given-names>E</given-names></name><name><surname>Lemeshow</surname><given-names>S</given-names></name><name><surname>Salamon</surname><given-names>R</given-names></name></person-group><article-title>European system for cardiac operative risk evaluation (EuroSCORE)</article-title><source>Eur J Cardiothorac Surg</source><year>1999</year><volume>16</volume><fpage>9</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">10456395</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>J</given-names></name><name><surname>Dent</surname><given-names>C</given-names></name><name><surname>Tarabishi</surname><given-names>R</given-names></name><name><surname>Mitsnefes</surname><given-names>MM</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Kelly</surname><given-names>C</given-names></name><etal/></person-group><article-title>Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery</article-title><source>Lancet</source><year>2005</year><volume>365</volume><fpage>1231</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15811456</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frangogiannis</surname><given-names>NG</given-names></name></person-group><article-title>Biomarkers: Hopes and challenges in the path from discovery to clinical practice</article-title><source>Transl Res</source><year>2012</year><volume>159</volume><fpage>197</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">22424424</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mythen</surname><given-names>MG</given-names></name><name><surname>Webb</surname><given-names>AR</given-names></name></person-group><article-title>Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery</article-title><source>Arch Surg</source><year>1995</year><volume>130</volume><fpage>423</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">7535996</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000f6;l&#x000f6;nen</surname><given-names>P</given-names></name><name><surname>Ruokonen</surname><given-names>E</given-names></name><name><surname>Hippel&#x000e4;inen</surname><given-names>M</given-names></name><name><surname>P&#x000f6;yh&#x000f6;nen</surname><given-names>M</given-names></name><name><surname>Takala</surname><given-names>J</given-names></name></person-group><article-title>A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients</article-title><source>Anesth Analg</source><year>2000</year><volume>90</volume><fpage>1052</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">10781452</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>RH</given-names></name><name><surname>Klughaupt</surname><given-names>M</given-names></name><name><surname>Metcalf</surname><given-names>T</given-names></name><name><surname>Spivack</surname><given-names>AP</given-names></name><name><surname>Harrison</surname><given-names>DC</given-names></name></person-group><article-title>Measurement of central venous oxygen saturation in patients with myocarial infarction</article-title><source>Circulation</source><year>1968</year><volume>38</volume><fpage>941</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">5697690</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Wright</surname><given-names>F</given-names></name><name><surname>Barber</surname><given-names>R</given-names></name><name><surname>Stanley</surname><given-names>L</given-names></name></person-group><article-title>Central venous oxygen saturation in shock: A study in man</article-title><source>Anesthesiology</source><year>1972</year><volume>36</volume><fpage>472</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">4553795</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKendry</surname><given-names>M</given-names></name><name><surname>McGloin</surname><given-names>H</given-names></name><name><surname>Saberi</surname><given-names>D</given-names></name><name><surname>Caudwell</surname><given-names>L</given-names></name><name><surname>Brady</surname><given-names>AR</given-names></name><name><surname>Singer</surname><given-names>M</given-names></name></person-group><article-title>Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery</article-title><source>BMJ</source><year>2004</year><volume>329</volume><fpage>258</fpage><pub-id pub-id-type="pmid">15242867</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakeling</surname><given-names>HG</given-names></name><name><surname>McFall</surname><given-names>MR</given-names></name><name><surname>Jenkins</surname><given-names>CS</given-names></name><name><surname>Woods</surname><given-names>WG</given-names></name><name><surname>Miles</surname><given-names>WF</given-names></name><name><surname>Barclay</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery</article-title><source>Br J Anaesth</source><year>2005</year><volume>95</volume><fpage>634</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">16155038</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>TJ</given-names></name><name><surname>Soppitt</surname><given-names>A</given-names></name><name><surname>Maroof</surname><given-names>M</given-names></name><name><surname>el-Moalem</surname><given-names>H</given-names></name><name><surname>Robertson</surname><given-names>KM</given-names></name><name><surname>Moretti</surname><given-names>E</given-names></name><etal/></person-group><article-title>Goal-directed intraoperative fluid administration reduces length of hospital stay after major surgery</article-title><source>Anesthesiology</source><year>2002</year><volume>97</volume><fpage>820</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">12357146</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manecke</surname><given-names>GR</given-names><suffix>Jr</suffix></name><name><surname>Auger</surname><given-names>WR</given-names></name></person-group><article-title>Cardiac output determination from the arterial pressure wave: Clinical testing of a novel algorithm that does not require calibration</article-title><source>J Cardiothorac Vasc Anesth</source><year>2007</year><volume>21</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17289472</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGee</surname><given-names>WT</given-names></name><name><surname>Horswell</surname><given-names>JL</given-names></name><name><surname>Calderon</surname><given-names>J</given-names></name><name><surname>Janvier</surname><given-names>G</given-names></name><name><surname>Van Severen</surname><given-names>T</given-names></name><name><surname>Van den Berghe</surname><given-names>G</given-names></name><etal/></person-group><article-title>Validation of a continuous, arterial pressure-based cardiac output measurement: A multicenter, prospective clinical trial</article-title><source>Crit Care</source><year>2007</year><volume>11</volume><fpage>R105</fpage><pub-id pub-id-type="pmid">17880692</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakravarthy</surname><given-names>M</given-names></name><name><surname>Patil</surname><given-names>TA</given-names></name><name><surname>Jayaprakash</surname><given-names>K</given-names></name><name><surname>Kalligudd</surname><given-names>P</given-names></name><name><surname>Prabhakumar</surname><given-names>D</given-names></name><name><surname>Jawali</surname><given-names>V</given-names></name></person-group><article-title>Comparison of simultaneous estimation of cardiac output by four techniques in patients undergoing off-pump coronary artery bypass surgery &#x02013; A prospective observational study</article-title><source>Ann Card Anaesth</source><year>2007</year><volume>10</volume><fpage>121</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17644884</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opdam</surname><given-names>HI</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name></person-group><article-title>A pilot assessment of the FloTrac cardiac output monitoring system</article-title><source>Intensive Care Med</source><year>2007</year><volume>33</volume><fpage>344</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17063359</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smetkin</surname><given-names>AA</given-names></name><name><surname>Kirov</surname><given-names>MY</given-names></name><name><surname>Kuzkov</surname><given-names>VV</given-names></name><name><surname>Lenkin</surname><given-names>AI</given-names></name><name><surname>Eremeev</surname><given-names>AV</given-names></name><name><surname>Slastilin</surname><given-names>VY</given-names></name><etal/></person-group><article-title>Single transpulmonary thermodilution and continuous monitoring of central venous oxygen saturation during off-pump coronary surgery</article-title><source>Acta Anaesthesiol Scand</source><year>2009</year><volume>53</volume><fpage>505</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">19183113</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>A</given-names></name><name><surname>Cecconi</surname><given-names>M</given-names></name><name><surname>Hamilton</surname><given-names>M</given-names></name><name><surname>Poloniecki</surname><given-names>J</given-names></name><name><surname>Woods</surname><given-names>J</given-names></name><name><surname>Boyd</surname><given-names>O</given-names></name><etal/></person-group><article-title>Goal-directed therapy in high-risk surgical patients: A 15-year follow-up study</article-title><source>Intensive Care Med</source><year>2010</year><volume>36</volume><fpage>1327</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">20376431</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapoor</surname><given-names>PM</given-names></name><name><surname>Kakani</surname><given-names>M</given-names></name><name><surname>Chowdhury</surname><given-names>U</given-names></name><name><surname>Choudhury</surname><given-names>M</given-names></name><name><surname>Lakshmy</surname><given-names>KU</given-names></name></person-group><article-title>Early goal-directed therapy in moderate to high-risk cardiac surgery patients</article-title><source>Ann Card Anaesth</source><year>2008</year><volume>11</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">18182756</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassina</surname><given-names>T</given-names></name><name><surname>Putzu</surname><given-names>A</given-names></name><name><surname>Santambrogio</surname><given-names>L</given-names></name><name><surname>Villa</surname><given-names>M</given-names></name><name><surname>Licker</surname><given-names>MJ</given-names></name></person-group><article-title>Hemodynamic challenge to early mobilization after cardiac surgery: A pilot study</article-title><source>Ann Card Anaesth</source><year>2016</year><volume>19</volume><fpage>425</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">27397446</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>UK</given-names></name><name><surname>Sheil</surname><given-names>A</given-names></name><name><surname>Kapoor</surname><given-names>PM</given-names></name><name><surname>Narang</surname><given-names>R</given-names></name><name><surname>Gharde</surname><given-names>P</given-names></name><name><surname>Malik</surname><given-names>V</given-names></name><etal/></person-group><article-title>Short-term prognostic value of perioperative coronary sinus-derived-serum cardiac troponin-I, creatine kinase-MB, lactate, pyruvate, and lactate-pyruvate ratio in adult patients undergoing open heart surgery</article-title><source>Ann Card Anaesth</source><year>2016</year><volume>19</volume><fpage>439</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">27397448</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bignami</surname><given-names>E</given-names></name><name><surname>Frati</surname><given-names>E</given-names></name><name><surname>Meroni</surname><given-names>R</given-names></name><name><surname>Simonini</surname><given-names>M</given-names></name><name><surname>Di Prima</surname><given-names>AL</given-names></name><name><surname>Manunta</surname><given-names>P</given-names></name><etal/></person-group><article-title>Urinary neutrophil gelatinase-associated lipocalin time course during cardiac surgery</article-title><source>Ann Card Anaesth</source><year>2015</year><volume>18</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">25566710</pub-id></element-citation></ref></ref-list></back></article>